M. Dominici, L. Blanc, K. Mueller, I. Slaper-cortenbach, I. Marini et al., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, vol.8, issue.4, pp.315-322, 2006.
DOI : 10.1080/14653240600855905

A. Friedenstein, J. Gorskaja, and N. Kulagina, Fibroblast precursors in normal and irradiated mouse hematopoietic organs, Exp Hematol, vol.4, pp.267-74, 1976.

M. Pittenger, A. Mackay, S. Beck, R. Jaiswal, R. Douglas et al., Multilineage Potential of Adult Human Mesenchymal Stem Cells, Science, vol.284, issue.5411, pp.143-147, 1999.
DOI : 10.1126/science.284.5411.143

P. Zuk, M. Zhu, P. Ashjian, D. Ugarte, D. Huang et al., Human Adipose Tissue Is a Source of Multipotent Stem Cells, Molecular Biology of the Cell, vol.13, issue.12, pp.4279-95, 2002.
DOI : 10.1091/mbc.E02-02-0105

L. Da-silva-meirelles, P. Chagastelles, and N. Nardi, Mesenchymal stem cells reside in virtually all post-natal organs and tissues, Journal of Cell Science, vol.119, issue.11, pp.2204-2217, 2006.
DOI : 10.1242/jcs.02932

P. Amé-thomas, M. Hajjami, H. Monvoisin, C. Jean, R. Monnier et al., Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis, Blood, vol.109, issue.2, pp.693-702, 2007.
DOI : 10.1182/blood-2006-05-020800

M. Krampera, S. Sartoris, L. Cosmi, A. Pasini, R. Angeli et al., Immune Regulation by Mesenchymal Stem Cells Derived from Adult Spleen and Thymus, Stem Cells and Development, vol.16, issue.5, pp.797-810, 2007.
DOI : 10.1089/scd.2007.0024

S. Gronthos, S. Graves, S. Ohta, and P. Simmons, The STRO1+ fraction of adult human bone marrow contains the osteogenic precursors, Blood, vol.84, pp.4164-73, 1994.

S. Shi and S. Gronthos, Perivascular Niche of Postnatal Mesenchymal Stem Cells in Human Bone Marrow and Dental Pulp, Journal of Bone and Mineral Research, vol.263, issue.4, pp.694-704, 2003.
DOI : 10.1359/jbmr.2003.18.4.696

B. Brachvogel, H. Moch, F. Pausch, U. Schlotzer-schrehardt, C. Hofmann et al., Perivascular cells expressing annexin A5 define a novel mesenchymal stem cell-like population with the capacity to differentiate into multiple mesenchymal lineages, Development, vol.132, issue.11, pp.2657-68, 2005.
DOI : 10.1242/dev.01846

M. Crisan, S. Yap, L. Casteilla, C. Chen, M. Corselli et al., A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human Organs, Cell Stem Cell, vol.3, issue.3, pp.301-314, 2008.
DOI : 10.1016/j.stem.2008.07.003

D. Covas, R. Panepucci, A. Fontes, W. Silva, . Jr et al., Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts, Experimental Hematology, vol.36, issue.5, pp.642-54, 2008.
DOI : 10.1016/j.exphem.2007.12.015

S. Batouli, M. Miura, J. Brahim, T. Tsutsui, L. Fisher et al., Comparison of Stem-cell-mediated Osteogenesis and Dentinogenesis, Journal of Dental Research, vol.82, issue.12, pp.976-81, 2003.
DOI : 10.1177/154405910308201208

Y. Takashima, T. Era, K. Nakao, S. Kondo, M. Kasuga et al., Neuroepithelial Cells Supply an Initial Transient Wave of MSC Differentiation, Cell, vol.129, issue.7, pp.1377-88, 2007.
DOI : 10.1016/j.cell.2007.04.028

S. Mendez-ferrer, T. Michurina, F. Ferraro, A. Mazloom, B. Macarthur et al., Mesenchymal and haematopoietic stem cells form a unique bone marrow niche, Nature, vol.8, issue.7308, pp.829-863, 2010.
DOI : 10.1038/nature09262

N. Quirici, D. Soligo, P. Bossolasco, F. Servida, C. Lumini et al., Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies, Experimental Hematology, vol.30, issue.7, pp.783-91, 2002.
DOI : 10.1016/S0301-472X(02)00812-3

B. Sacchetti, A. Funari, S. Michienzi, D. Cesare, S. Piersanti et al., Self-Renewing Osteoprogenitors in Bone Marrow Sinusoids Can Organize a Hematopoietic Microenvironment, Cell, vol.131, issue.2, pp.324-360, 2007.
DOI : 10.1016/j.cell.2007.08.025

M. Ricciardi, G. Malpeli, F. Bifari, G. Bassi, L. Pacelli et al., Comparison of Epithelial Differentiation and Immune Regulatory Properties of Mesenchymal Stromal Cells Derived from Human Lung and Bone Marrow, PLoS ONE, vol.31, issue.5, p.35639, 2012.
DOI : 10.1371/journal.pone.0035639.t002

S. Jones, N. Horwood, A. Cope, and F. Dazzi, The Antiproliferative Effect of Mesenchymal Stem Cells Is a Fundamental Property Shared by All Stromal Cells, The Journal of Immunology, vol.179, issue.5, pp.2824-2855, 2007.
DOI : 10.4049/jimmunol.179.5.2824

D. Nicola, M. Carlo-stella, C. Magni, M. Milanesi, M. Longoni et al., Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli, Blood, vol.99, issue.10, pp.3838-3843, 2002.
DOI : 10.1182/blood.V99.10.3838

A. Uccelli, L. Moretta, and V. Pistoia, Mesenchymal stem cells in health and disease, Nature Reviews Immunology, vol.2, issue.9, pp.726-762, 2008.
DOI : 10.1038/nri2395

A. Nauta and W. Fibbe, Immunomodulatory properties of mesenchymal stromal cells, Blood, vol.110, issue.10, pp.3499-506, 2007.
DOI : 10.1182/blood-2007-02-069716

R. Meisel, S. Brockers, K. Heseler, O. Degistirici, H. Bülle et al., Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase, Leukemia, vol.176, issue.4, pp.648-654, 2011.
DOI : 10.1016/j.humimm.2004.02.022

R. Waterman, S. Tomchuck, S. Henkle, and A. Betancourt, A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype, PLoS ONE, vol.5, issue.4, p.10088, 2010.
DOI : 10.1371/journal.pone.0010088.s002

M. Krampera, Mesenchymal stromal cell ???licensing???: a multistep process, Leukemia, vol.65, issue.9, pp.1408-1414, 2011.
DOI : 10.1038/leu.2011.108

L. Blanc, K. Rasmusson, I. Sundberg, B. Gotherstrom, C. Hassan et al., Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells, The Lancet, vol.363, issue.9419, pp.1439-1441, 2004.
DOI : 10.1016/S0140-6736(04)16104-7

L. Blanc, K. Frassoni, F. Ball, L. Locatelli, F. Roelofs et al., Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study, The Lancet, vol.371, issue.9624, pp.1579-1586, 2008.
DOI : 10.1016/S0140-6736(08)60690-X

E. Gonzalez-rey, P. Anderson, M. Gonzalez, L. Rico, D. Buscher et al., Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis, Gut, vol.58, issue.7, pp.929-939, 2009.
DOI : 10.1136/gut.2008.168534

F. Togel, Z. Hu, K. Weiss, J. Isaac, C. Lange et al., Amelioration of Acute Renal Failure by Stem Cell Therapy--Paracrine Secretion Versus Transdifferentiation into Resident Cells: Administered Mesenchymal Stem Cells Protect against Ischemic Acute Renal Failure through Differentiation-Independent Mechanisms. Am J Physiol Renal Physiol E-pub February 15, 2005, Journal of the American Society of Nephrology, vol.16, issue.5, pp.1153-1163, 2005.
DOI : 10.1681/ASN.2005030294

E. Zappia, S. Casazza, E. Pedemonte, F. Benvenuto, I. Bonanni et al., Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy, Blood, vol.106, issue.5, pp.1755-1761, 2005.
DOI : 10.1182/blood-2005-04-1496

G. Constantin, S. Marconi, B. Rossi, S. Angiari, L. Calderan et al., Adipose-Derived Mesenchymal Stem Cells Ameliorate Chronic Experimental Autoimmune Encephalomyelitis, Stem Cells, vol.210, issue.10, pp.2624-2635, 2009.
DOI : 10.1002/stem.194

F. Dazzi and M. Krampera, Mesenchymal stem cells and autoimmune diseases, Best Practice & Research Clinical Haematology, vol.24, issue.1, pp.49-57, 2011.
DOI : 10.1016/j.beha.2011.01.002

E. Horwitz, L. Blanc, K. Dominici, M. Mueller, I. Slaper-cortenbach et al., Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement, Cytotherapy, vol.7, issue.5, pp.393-395, 2005.
DOI : 10.1080/14653240500319234

J. Chan, K. Tang, A. Patel, L. Bonilla, N. Pierobon et al., Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-??, Blood, vol.107, issue.12, pp.4817-4824, 2006.
DOI : 10.1182/blood-2006-01-0057

M. Francois, R. Romieu-mourez, S. Stock-martineau, M. Boivin, J. Bramson et al., Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties, Blood, vol.114, issue.13, pp.2632-2638, 2009.
DOI : 10.1182/blood-2009-02-207795

M. Krampera, L. Cosmi, R. Angeli, A. Pasini, F. Liotta et al., Role for Interferon-?? in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells, Stem Cells, vol.4, issue.(suppl 2), pp.386-398, 2006.
DOI : 10.1634/stemcells.2005-0008

M. François, R. Romieu-mourez, M. Li, and J. Galipeau, Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3-Dioxygenase and Bystander M2 Macrophage Differentiation, Molecular Therapy, vol.20, issue.1, pp.187-195, 2012.
DOI : 10.1038/mt.2011.189

M. François, I. Copland, S. Yuan, R. Romieu-mourez, E. Waller et al., Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-?? licensing, Cytotherapy, vol.14, issue.2, pp.147-152, 2012.
DOI : 10.3109/14653249.2011.623691

L. Sensebé, P. Bourin, and K. Tarte, Good Manufacturing Practices Production of Mesenchymal Stem/Stromal Cells, Human Gene Therapy, vol.22, issue.1, pp.19-26, 2011.
DOI : 10.1089/hum.2010.197

E. Traggiai, S. Volpi, F. Schena, M. Gattorno, F. Ferlito et al., Bone Marrow-Derived Mesenchymal Stem Cells Induce Both Polyclonal Expansion and Differentiation of B Cells Isolated from Healthy Donors and Systemic Lupus Erythematosus Patients, Stem Cells, vol.62, issue.2, pp.562-569, 2008.
DOI : 10.1634/stemcells.2007-0528

M. Krampera, G. S. Dyson, J. Scott, D. Laylor, R. Simpson et al., Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide, Blood, vol.101, issue.9, pp.3722-3729, 2003.
DOI : 10.1182/blood-2002-07-2104

S. Glennie, I. Soeiro, P. Dyson, E. Lam, and F. Dazzi, Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells, Blood, vol.105, issue.7, pp.2821-2827, 2005.
DOI : 10.1182/blood-2004-09-3696

R. Ramasamy, C. Tong, H. Seow, S. Vidyadaran, and F. Dazzi, The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function, Cellular Immunology, vol.251, issue.2, pp.131-136, 2008.
DOI : 10.1016/j.cellimm.2008.04.009

C. Menard, L. Pacelli, G. Bassi, J. Dulong, F. Bifari et al., on behalf of CASCADE cooperative group (FP7-HEALTH-233236) Clinical-grade mesenchymal stromal cells produced under various GMP processes differ in their immunomodulatory properties: Standardization of immune quality controls, Stem Cells and Development

L. Blanc, K. Tammik, C. Rosendahl, K. Zetterberg, E. Ringdén et al., HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells, Experimental Hematology, vol.31, issue.10, pp.890-896, 2003.
DOI : 10.1016/S0301-472X(03)00110-3

L. Blanc, K. Tammik, L. Sundberg, B. Haynesworth, S. Ringdén et al., Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex, Scandinavian Journal of Immunology, vol.15, issue.1, pp.11-20, 2003.
DOI : 10.1097/00007890-199911150-00024

F. Liotta, R. Angeli, L. Cosmi, L. Fili, C. Manuelli et al., Toll-Like Receptors 3 and 4 Are Expressed by Human Bone Marrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-Cell Modulatory Activity by Impairing Notch Signaling, Stem Cells, vol.18, issue.1, pp.279-289, 2008.
DOI : 10.1634/stemcells.2007-0454

C. Götherström, A. Lundqvist, I. Duprez, R. Childs, L. Berg et al., Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways, Cytotherapy, vol.13, issue.3, pp.269-278, 2011.
DOI : 10.3109/14653249.2010.523077

P. Sotiropoulou, S. Perez, A. Gritzapis, C. Baxevanis, and M. Papamichail, Interactions Between Human Mesenchymal Stem Cells and Natural Killer Cells, Stem Cells, vol.24, issue.1, pp.74-85, 2006.
DOI : 10.1634/stemcells.2004-0359

S. Tabera, J. Pérez-simón, M. Díez-campelo, L. Sánchez-abarca, B. Blanco et al., The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes, Haematologica, vol.93, issue.9, pp.1301-1309, 2008.
DOI : 10.3324/haematol.12857

A. Corcione, F. Benvenuto, E. Ferretti, D. Giunti, V. Cappiello et al., Human mesenchymal stem cells modulate B-cell functions, Blood, vol.107, issue.1, pp.367-372, 2006.
DOI : 10.1182/blood-2005-07-2657

R. Maccario, M. Podestà, A. Moretta, A. Cometa, P. Comoli et al., Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype, Haematologica, vol.90, pp.516-525, 2005.

S. Aggarwal and M. Pittenger, Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, vol.105, issue.4, pp.1815-1822, 2004.
DOI : 10.1182/blood-2004-04-1559

J. Kim and P. Hematti, Mesenchymal stem cell???educated macrophages: A novel type of alternatively activated macrophages, Experimental Hematology, vol.37, issue.12, pp.1445-1453, 2009.
DOI : 10.1016/j.exphem.2009.09.004

K. Németh, A. Leelahavanichkul, P. Yuen, B. Mayer, A. Parmelee et al., Bone marrow stromal cells attenuate sepsis via prostaglandin E2???dependent reprogramming of host macrophages to increase their interleukin-10 production, Nature Medicine, vol.16, issue.1, pp.42-49, 2009.
DOI : 10.1006/bbrc.1996.1112

L. Raffaghello, G. Bianchi, M. Bertolotto, F. Montecucco, A. Busca et al., Human Mesenchymal Stem Cells Inhibit Neutrophil Apoptosis: A Model for Neutrophil Preservation in the Bone Marrow Niche, Stem Cells, vol.38, issue.1, pp.151-162, 2008.
DOI : 10.1634/stemcells.2007-0416

M. Cassatella, F. Mosna, A. Micheletti, V. Lisi, N. Tamassia et al., Toll-Like Receptor-3-Activated Human Mesenchymal Stromal Cells Significantly Prolong the Survival and Function of Neutrophils, STEM CELLS, vol.52, issue.6, pp.1001-1011, 2011.
DOI : 10.1002/stem.651

R. Meisel, A. Zibert, M. Laryea, U. Gobel, W. Daubener et al., Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation, Blood, vol.103, issue.12, pp.4619-4621, 2004.
DOI : 10.1182/blood-2003-11-3909

G. Ren, L. Zhang, X. Zhao, G. Xu, Y. Zhang et al., Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide, Cell Stem Cell, vol.2, issue.2, pp.141-150, 2008.
DOI : 10.1016/j.stem.2007.11.014

A. Bartholomew, C. Sturgeon, M. Siatskas, K. Ferrer, K. Mcintosh et al., Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo, Experimental Hematology, vol.30, issue.1, pp.42-48, 2002.
DOI : 10.1016/S0301-472X(01)00769-X

D. Polchert, J. Sobinsky, G. Douglas, M. Kidd, A. Moadsiri et al., IFN-?? activation of mesenchymal stem cells for treatment and prevention of graft versus host disease, European Journal of Immunology, vol.90, issue.6, pp.1745-1455, 2008.
DOI : 10.1002/eji.200738129

V. Tisato, K. Naresh, J. Girdlestone, C. Navarrete, and F. Dazzi, Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease, Leukemia, vol.176, issue.9, pp.1992-1999, 2007.
DOI : 10.1038/10563

F. Dazzi and F. Marelli-berg, Mesenchymal stem cells for graft-versus-host disease: Close encounters with T cells, European Journal of Immunology, vol.19, issue.6, pp.1479-1482, 2008.
DOI : 10.1002/eji.200838433

N. Gupta, X. Su, B. Popov, J. Lee, V. Serikov et al., Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice, The Journal of Immunology, vol.179, issue.3, pp.1855-1863, 2007.
DOI : 10.4049/jimmunol.179.3.1855

J. Galipeau, The mesenchymal stromal cells dilemma???does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?, Cytotherapy, vol.15, issue.1, pp.2-8, 2013.
DOI : 10.1016/j.jcyt.2012.10.002